PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France; Faculté de Pharmacie, Université Paris-Saclay, 92296 Châtenay-Malabry, France. Electronic address: jeremie.botton@ansm.sante.fr.\', \'EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France.\', \'EPI-PHARE Scientific Interest Group in Epidemiology of Health Products of the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, France; University Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective evasion and Pharmacoepidemiology, CESP, 78180 Montigny le Bretonneux, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)01617-010.1016/j.vaccine.2021.12.009
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34924220
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all